Imaging Features of Small Vessel Disease in Cerebral Amyloid Angiopathy Among Patients with Alzheimer’s Disease

[1]  Hanna Cho,et al.  Role of Enlarged Perivascular Space in the Temporal Lobe in Cerebral Amyloidosis , 2023, Annals of neurology.

[2]  Mingliang Wang,et al.  Associations of MRI-visible perivascular spaces with longitudinal cognitive decline across the Alzheimer’s disease spectrum , 2022, Alzheimer's research & therapy.

[3]  C. Jack,et al.  Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice , 2022, American Journal of Neuroradiology.

[4]  J. Schneider,et al.  The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study , 2022, The Lancet Neurology.

[5]  M. Verbeek,et al.  Prevalence of cerebral amyloid angiopathy: A systematic review and meta‐analysis , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[6]  Y. Ryu,et al.  MRI-Visible Perivascular Spaces in the Centrum Semiovale Are Associated with Brain Amyloid Deposition in Patients with Alzheimer Disease–Related Cognitive Impairment , 2021, American Journal of Neuroradiology.

[7]  J. Jeng,et al.  Centrum Semiovale Perivascular Space and Amyloid Deposition in Spontaneous Intracerebral Hemorrhage , 2021, Stroke.

[8]  Eric E. Smith,et al.  Abstract 36: The Boston Criteria V2.0 for Cerebral Amyloid Angiopathy: Updated Criteria and Multicenter MRI-Neuropathology Validation , 2021 .

[9]  O. Hansson,et al.  Association of Enlarged Perivascular Spaces and Measures of Small Vessel and Alzheimer Disease , 2020, Neurology.

[10]  R. Sperling,et al.  Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways , 2019, Nature Reviews Neurology.

[11]  Eric E. Smith,et al.  Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0 , 2019, International journal of stroke : official journal of the International Stroke Society.

[12]  C. Jack,et al.  White matter hyperintensities: relationship to amyloid and tau burden. , 2019, Brain : a journal of neurology.

[13]  L. Beckett,et al.  White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities , 2019, Alzheimer's & dementia.

[14]  J. Pell,et al.  Association between APOE e4 and white matter hyperintensity volume, but not total brain volume or white matter integrity , 2019, Brain Imaging and Behavior.

[15]  M. van Buchem,et al.  Perivascular Spaces Volume in Sporadic and Hereditary (Dutch-Type) Cerebral Amyloid Angiopathy , 2018, Stroke.

[16]  J. Whitwell,et al.  Alzheimer's disease neuroimaging , 2018, Current opinion in neurology.

[17]  Lilah M. Besser,et al.  The Revised National Alzheimer’s Coordinating Center’s Neuropathology Form—Available Data and New Analyses , 2018, Journal of neuropathology and experimental neurology.

[18]  Michael Weiner,et al.  White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer’s disease , 2018, PloS one.

[19]  S. Greenberg,et al.  Diagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria. , 2018, Stroke.

[20]  J. Molinuevo,et al.  Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45–75: Results from the ALFA study , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  S. Greenberg,et al.  Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease , 2017, Neurology.

[22]  M. Jorge Cardoso,et al.  APOE 4 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis , 2018 .

[23]  Sang Won Seo,et al.  MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden , 2017, Brain : a journal of neurology.

[24]  Andreas Charidimou,et al.  MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy , 2017, Neurology.

[25]  S. Greenberg,et al.  Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage , 2017, Neurology.

[26]  S. Greenberg,et al.  White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy , 2016, Neurology.

[27]  S. Greenberg,et al.  Ischemic brain injury in cerebral amyloid angiopathy , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  Lilah M. Besser,et al.  Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes , 2015, Neurobiology of Aging.

[29]  Peter R Luijten,et al.  Cerebral amyloid angiopathy severity is linked to dilation of juxtacortical perivascular spaces , 2015, Alzheimer's & Dementia.

[30]  Young T. Hong,et al.  White Matter Perivascular Spaces on Magnetic Resonance Imaging: Marker of Cerebrovascular Amyloid Burden? , 2015, Stroke.

[31]  P. Scheltens,et al.  White matter hyperintensities, cognitive impairment and dementia: an update , 2015, Nature Reviews Neurology.

[32]  J. Wardlaw,et al.  Cerebral Perivascular Spaces Visible on Magnetic Resonance Imaging: Development of a Qualitative Rating Scale and its Observer Reliability , 2015, Cerebrovascular Diseases.

[33]  J. Baron,et al.  White matter perivascular spaces , 2014, Neurology.

[34]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[35]  Anand Viswanathan,et al.  Topography of dilated perivascular spaces in subjects from a memory clinic cohort , 2013, Neurology.

[36]  Keith A. Johnson,et al.  Cerebral amyloid angiopathy burden associated with leukoaraiosis: A positron emission tomography/magnetic resonance imaging study , 2013, Annals of neurology.

[37]  J. Schneider,et al.  National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.

[38]  Carole Dufouil,et al.  Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging , 2012, Journal of Neurology.

[39]  Clifford R. Jack,et al.  Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup , 2011, Alzheimer's & Dementia.

[40]  W. M. van der Flier,et al.  Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[41]  O Almkvist,et al.  Visual Rating of Age-Related White Matter Changes on Magnetic Resonance Imaging: Scale Comparison, Interrater Agreement, and Correlations With Quantitative Measurements , 2003, Stroke.

[42]  L. Thal,et al.  Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. , 2000, Archives of neurology.

[43]  S. Greenberg,et al.  Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. , 1997, Stroke.

[44]  J. Vonsattel,et al.  Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study , 1991, Annals of neurology.

[45]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.